- Research Digest
14 Results
Lighting the Way to Antibody Drugs against Human Metapneumovirus
From human memory B cells, researchers at Merck & Co. have recently isolated over a hundred monoclonal antibodies that specifically target human metapneumovirus, a common cause of acute lower respiratory infection in children.
06-20-2022Read More »
CAR (NAP) T Cell, An Armed CAR T Cell Revolutionizing Cancer Immunotherapy
Researchers at Uppsala University have recently developed novel CAR T cells that outcompete conventional ones and induce advantageous immunological responses against solid tumors in mouse models.
05-18-2022Read More »
Perturb-map, A New Technology Cracking Tumor Microenvironment Mystery
Perturb-map is a new spatial functional genomics technology that unravels the mystery of tumor microenvironment and speeds up the discovery of new targets for better cancer therapies.
05-11-2022Read More »
SEAKER, A New Type of CAR T Cell for Better Cancer Treatment
Researchers from Sloan Kettering Cancer Center recently designed a new type of CAR T cell that overcomes many hurdles of regular CAR T cell therapy and greatly enhances the anti-tumor efficacy of genetically engineered T cells.
03-17-2022Read More »
Evaluating SARS-CoV-2 Immune Memory in a Golden Hamster Model
Learn how investigators leverage the golden hamster model system to understand adaptive immune memory responses to SARS-CoV-2 and VOC.
01-17-2022Read More »
Researchers Found New “Eyes” of Immune System to Detect Cancer Cells
Researchers from Oslo University Hospital recently found an appealing cancer target named TdT for short, providing new "eyes" of immune system to detect cancer cells.
01-09-2022Read More »
More RNA Vaccines: More Hopes for Stopping the Pandemic
Various vaccines based on different types of RNA are now under development to fight emerging SARS-CoV-2 variants, bringing new hopes for stopping the long-standing pandemic.
09-28-2021Read More »
Regulating Cas Proteins: A Chemical Toolbox Aiding Genome Editing
Off-target effects remain a major concern in CRISPR-mediated immunotherapies. Read on and learn how a chemical toolbox can be developed in an effort to overcome this problem.
09-16-2021Read More »
